Ectopic expression of DICE1 suppresses tumor cell growth

Oncology Reports

Volumn 12, Issue 2, 2004, Pages 207-211

  Wieland, Ilse ^a   Sell, Christian ^b   Weidle, Ulrich H ^c   Wieacker, P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

13q14; DICE1; Growth inhibition; Tumor suppressor gene

Indexed keywords

AGAR; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; INTS6 PROTEIN, HUMAN; MESSENGER RNA; RIBOSOME PROTEIN; RNA; RNA HELICASE; SOMATOMEDIN C; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL PROLIFERATION; CHEMISTRY; EXON; HUMAN; METABOLISM; MOUSE; NEOPLASM; NORTHERN BLOTTING; PLASMID; PROTEIN MOTIF; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

AGAR; AMINO ACID MOTIFS; ANIMALS; BLOTTING, NORTHERN; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, COMPLEMENTARY; EXONS; GENES, TUMOR SUPPRESSOR; GREEN FLUORESCENT PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED BALB C; NEOPLASMS; PLASMIDS; RECOMBINANT FUSION PROTEINS; RIBOSOMAL PROTEINS; RNA; RNA HELICASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 16544373272     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.2.207     Document Type: Article

References (30)

1. Tamura K, Zhang X, Murakami Y, Hirohashi S, Xu H-J, Hu S-X, Benedict WF and Sekiya T: Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int J Cancer 74: 45-49, 1997. (Pubitemid 27157854)
2. Ogawara K, Miyakawa A, Shiba M, Uzawa K, Watanabe T, Wang XL, Sato T, Kubosawa H, Kondo Y and Tanzawa H: Allelic loss of chromosome 13q14.3 in human oral cancer: correlation with lymph node metastasis. Int J Cancer 79: 312-317, 1998. (Pubitemid 28359726)
3. Ueda T, Emi M, Suzuki H, Komiya A, Akakura K, Ichikawa T, Watanabe M, Shiraishi T, Masai M, Igarashi T and Ito H: Identification of a 1-cM region of common deletion on 13q14 associated with human prostate cancer. Genes Chromsomes Cancer 24: 183-190, 1999. (Pubitemid 29070156)
4. Afonso A, Emmert-Buck MR, Duray PH, Bostwick DG, Linehan WM and Vocke CD: Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer. J Urol 162: 922-926, 1999. (Pubitemid 29436918)
5. Yin Z, Spitz MR, Babaian RJ, Strom SS, Troncoso P and Kagan J: Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene 18: 7576-7583, 1999. (Pubitemid 30035059)
6. Simpson DJ, Magnay J, Bicknell JE, Barkan AL, McNicol AM, Clayton RN and Farrell WE: Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas. Cancer Res 59: 1562-1566, 1999. (Pubitemid 29160126)
7. Liu Y, Hermanson M, Grander D, Merup M, Wu X, Heyman M, Rasool O, Juliusson G, Gahrton G, Detlofsson R, et al: 13q deletions in lymphoid malignancies. Blood 86: 1911-1915, 1995.
8. Lin J, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C, Xu K, Yen N, Atkinson EN, Fang B, Lerman MI, Roth JA and Minna JD: Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 62: 2715-2720, 2002. (Pubitemid 34462757)
9. Lerman MI and Minna JD: The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. Cancer Res 60: 6116-6133, 2000.
10. Wieland I, Arden KC, Michels D, Klein-Hitpass L, Böhm M, Viars CS and Weidle UH: Isolation of DICE1: A gene frequently affected by LOH and downregulated in lung carcinomas. Oncogene 18: 4530-4537, 1999. (Pubitemid 29405884)
11. Wieland I, Röpke A, Stumm M, Sell C, Weidle UH and Wieacker PF: Molecular characterization of the DICE1 (DDX26) tumor suppressor gene in lung carcinoma cells. Oncol Res 12: 491-500, 2001.
12. Li WJ, Hu N, Su H, Wang C, Goldstein AM, Wang Y, Emmert-Buck MR, Roth MJ, Guo W-J and Taylor PR: Allelic loss on chromosome 13q14 and mutation in deleted in cancer 1 gene in esophageal squamous cell carcinoma. Oncogene 22: 314-318, 2003. (Pubitemid 36174189)
13. Latil A, Morant P, Fournier G, Mangin P, Berthon P and Cussenot O: CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2 is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer. Int J Cancer 99: 689-696, 2002. (Pubitemid 34538748)
14. Mertens D, Wolf S, Schroeter P, Schaffner C, Döhner H, Stilgenbauer S and Lichter P: Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 99: 4116-4121, 2002. (Pubitemid 35332055)
15. Sossey-Alaoui K, Kitamura E, Head K and Cowell JK: Characterization of FAM10A4, a member of the ST13 tumor suppressor gene family that maps to the 13q14.3 region associated with B-cell leukemia, multiple myeloma, and prostate cancer. Genomics 80: 5-7, 2002. (Pubitemid 34701399)
16. Pear WS, Nolan GP, Scott ML and Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90: 8392-8396, 1993. (Pubitemid 23277674)
17. Pietrzkowski Z, Sell C, Lammers R, Ullrich A and Baserga R: Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell Biol 12: 3883-3889, 1992.
18. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
19. Morgenstern JP and Land H: Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18: 3587-3596, 1990.
20. Klein G: Introduction: genetic and epigenetic contributions to tumor evolution. Sem Cancer Biol 12: 327-330, 2002.
21. Strathdee G: Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol 12: 373-379, 2002.
22. Whittaker CA and Hynes RO: Distribution and evolution of von willebrand/integrin a domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol Biol Cell 13: 3369-3387, 2002. (Pubitemid 35191361)
23. Garkavtsev IV, Kley N, Grigorian IA and Gudkov AV: The Bloom syndrome protein interacts and cooperates with p53 in regulation of transcription and cell growth control. Oncogene 20: 8276-8280, 2001. (Pubitemid 34038215)
24. Myöhänen S and Baylin SB: Sequence-specific DNA binding activity of RNA helicase A to the p16INK4 promoter. J Biol Chem 276:1634-1642,2001. (Pubitemid 32098014)
25. Westermarck J, Weiss C, Saffrich R, Kast J, Musti AM, Wessely M, Ansorge W, Séraphin B, Wilm M, Valdez BC and Bohmann D: The DEX/H-box RNA helicase RHII/Gu is a cofactor for c-jun-activated transcription. EMBO J 21: 451-460, 2002. (Pubitemid 34137306)
26. Ellis N, Groden J, Ye T-Z, Staughen J, Lennon DJ, Ciocci S, Proytcheva M and German J: The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 83: 655-666, 1995.
27. Cahill DP, Kinzler KW, Vogelstein B and Lengauer C: Genetic instability and darwinian selection in tumours. TCB TIBS TIG Millennium issue: M57-M60, 1999.
28. Hoff HB III, Tresini M, Li S and Sell C: DBI-1, a novel gene related to the Notch family, modulates mitogenic response to insulin-like growth factor 1. Exp Cell Res 238: 359-370, 1998. (Pubitemid 28372823)
29. Baserga R: The contradictions of the insulin-like growth factor 1 receptor. Oncogene 19: 5574-5581, 2000.
30. Bourbon HM, Gonzy-Treboul G, Peronnet F, Alin MF, Ardourel C, Benassayag C, Cribbs D, Deutsch J, Ferrer P, Haenlin M, Lepesant JA, Noselli S and Vincent A: A P-insertion screen identifying novel X-linked essential genes in Drosophila. Mech Dev 110: 71-83, 2002.